Why Evolent Health Stock Is Jumping Today
The company released its quarterly update after the market closed on Thursday, and investors like what they saw.
Why BioCryst Pharmaceuticals Stock Is Falling Today
The company's fourth-quarter earnings report did not pass muster.
Why Akebia Therapeutics Stock Is Plunging Today
Investors were not impressed with the drugmaker's latest quarterly update.
Why Horizon Therapeutics Stock Jumped Today
The biopharmaceutical company released its latest quarterly update.
Why MannKind Corporation Stock Is Popping Today
An analyst is excited about the company's prospects.
Why PRA Health Sciences Stock Is Soaring Today
The company released its fourth-quarter earnings report, but that doesn't tell the whole story.
Why STAAR Surgical Stock Is Dropping Today
There isn't much for long-term investors to worry about.
Why Invitae Stock Is Falling Today
The healthcare company is diving along with the market.
Why Viatris Stock Plunged Today
The company released its guidance for its fiscal year 2021.
Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)
These two companies have exciting long-term prospects.
Why Quidel Corporation Stock Is Plunging Today
The company released its fourth-quarter and full-year 2020 earnings report.
Why Mednax Stock Is Plunging Today
The company released its earnings report for the fourth quarter.
Why Altimmune Stock Popped Today
The company's COVID-19 program is moving ahead.
Why Immunovant Stock Is Bouncing Back Today
The company is finally getting a break after a rough past couple of weeks.
2 Top Stocks to Buy for a Post-Pandemic World
These two pharma giants' recent struggles in the stock market represent a buying opportunity.
2 High-Growth Robinhood Stocks That Could Realistically Triple Your Money in 2021
These two biotech stocks could skyrocket even higher than they already have, but plenty of risk remains.
Why Immunovant Stock Dropped Today
Investors didn't respond well to the company's latest quarterly update.
Why bluebird bio Stock Is Plunging Today
The company had to halt one of its clinical studies following a suspected severe adverse reaction.
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
Once a leader in the COVID-19 vaccine race, does this biotech have what it takes to deliver market-shattering returns?
Why Mesoblast Limited Is Rising Today
One of its pipeline candidates achieved great results in a late-stage clinical study.